Sickle Cell Disease
What's New
Last Posted: Nov 17, 2023
- UK first to approve CRISPR treatment for diseases: what you need to know
C Wong. Nature. November 16, 2023 - Screening for haemoglobin disorders: One size may not fit all.
Lisa M Shook et al. Br J Haematol 2023 - A Newborn Screening Program for Sickle Cell Disease in Murcia (Spain).
María Sánchez-Villalobos et al. Int J Neonatal Screen 2023 9(4) - Impact of Genetic Variations on Thromboembolic Risk in Saudis with Sickle Cell Disease.
Mohammad A Alshabeeb et al. Genes (Basel) 2023 14(10) - Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis.
Justin K Kirkham et al. JAMA Netw Open 2023 10 (10) e2337484 - Implementation of Hospital-Based Sickle Cell Newborn Screening and Follow-Up Programs in Haiti.
Ofelia A Alvarez et al. Blood Adv 2023 - Outcomes and long-term effects of hematopoietic stem cell transplant in sickle cell disease.
Zaina Inam et al. Expert Rev Hematol 2023 - Current challenges and new approaches to implementing optimal management of sickle cell disease in sub-Saharan Africa.
Mwashungi Ally et al. Semin Hematol 2023 - Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan® and HemotypeSC®) on cord blood.
Aldiouma Guindo et al. Br J Haematol 2023 - Gene therapy for Hemoglobinopathies.
Maria Rosa Lidonnici et al. Hum Gene Ther 2023
More
About HLBS-PopOmics
HLBS-PopOmics is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to Heart and Vascular Diseases(H), Lung Diseases(L), Blood Diseases(B), and Sleep Disorders(S)...more
Content Summary
Common HLBS Health Categories
Site Citation:
Mensah GA, Yu W, Barfield WL, Clyne M, Engelgau MM, Khoury MJ. HLBS-PopOmics: an online knowledge base to accelerate dissemination and implementation of research advances in population genomics to reduce the burden of heart, lung, blood, and sleep disorders. Genet Med. 2018 Sep 10. doi: 10.1038/s41436-018-0118-1
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 27, 2023
- Content source: